Cost-effectiveness analysis of three drugs in treatment of male non-gonococcal urethritis
- Received Date: 2004-05-30
-
Key words:
- cost-effectiveness analysis /
- non-gonococcal urethritis /
- azithromycin /
- minocycline /
- fleroxacin
Abstract: Objective To evaluate the economic effects of azithromycin, minoeycline and fleroxacin in treatment of male non-gonococcal urethritis.Methods The evaluation was conducted by pharmacoeconomical cost-effectiveness analysis.Results The cure rate (89.29%) of azithromycin was the highest, and its additional cost was the lowest when the cure rate reached to 100%.Conclusion The best scheme was azithromycin in treatment of male non-gonococcal urethritis.
Citation: | GAO Guo-jian, TANG Zhi-hua, DING Jie-wei. Cost-effectiveness analysis of three drugs in treatment of male non-gonococcal urethritis[J]. Journal of Pharmaceutical Practice and Service, 2004, (6): 376-377,367. |